A61K 38/17
From animals
Official title: from animals; from humans {(enzyme inhibitors A61K38/005)}
A61K38/17 (From animals) appears on 24,160 US grants and 43,410 published applications in this corpus.
Search patents in A61K- Granted patents
- 24,160
- Published applications
- 43,410
- Assignees
- 10,496
- Inventors
- 57,714
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 9 | 0 |
| 1978 | 9 | 0 |
| 1979 | 9 | 0 |
| 1980 | 8 | 0 |
| 1981 | 3 | 0 |
| 1982 | 15 | 0 |
| 1983 | 10 | 0 |
| 1984 | 22 | 0 |
| 1985 | 21 | 0 |
| 1986 | 27 | 0 |
| 1987 | 34 | 0 |
| 1988 | 50 | 0 |
| 1989 | 84 | 0 |
| 1990 | 59 | 0 |
| 1991 | 92 | 0 |
| 1992 | 119 | 0 |
| 1993 | 159 | 0 |
| 1994 | 111 | 0 |
| 1995 | 139 | 0 |
| 1996 | 186 | 0 |
| 1997 | 324 | 0 |
| 1998 | 455 | 0 |
| 1999 | 429 | 0 |
| 2000 | 368 | 0 |
| 2001 | 389 | 189 |
| 2002 | 402 | 834 |
| 2003 | 371 | 1177 |
| 2004 | 331 | 1190 |
| 2005 | 327 | 1304 |
| 2006 | 429 | 1377 |
| 2007 | 415 | 1464 |
| 2008 | 461 | 1317 |
| 2009 | 520 | 1518 |
| 2010 | 694 | 1619 |
| 2011 | 680 | 1576 |
| 2012 | 805 | 1489 |
| 2013 | 884 | 1803 |
| 2014 | 1095 | 1990 |
| 2015 | 1173 | 2104 |
| 2016 | 1217 | 2258 |
| 2017 | 1313 | 2058 |
| 2018 | 1252 | 2086 |
| 2019 | 1362 | 2272 |
| 2020 | 1251 | 2140 |
| 2021 | 1267 | 2251 |
| 2022 | 1138 | 2294 |
| 2023 | 957 | 2013 |
| 2024 | 980 | 1962 |
| 2025 | 1013 | 1801 |
| 2026 | 686 | 1324 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition for use in treating dystrophic epidermolysis bullosa6 Oct 2026US 12,751,974 B2Osaka University
- Methods and compositions of chondrisomes6 Oct 2026US 12,751,977 B2Children's Medical Center Corporation
- Methods for treating pancreatic cancer and other solid tumors6 Oct 2026US 12,751,991 B2Lisata Therapeutics, Inc.
- Methods and compositions for treating cardiovascular diseases using fat specific protein 27 (FSP27) compositions6 Oct 2026US 12,751,992 B2Ohio University
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- Concentrated milk protein preparations8 Oct 2026US 2026/0305634 A150G Inc.
- Method to induce exfoliation of cells and/or tissue fragments for enhanced cytopathologic cell collection8 Oct 2026US 2026/0306077 A1Adenocyte Ltd.
- Compositions and methods for improving brain health8 Oct 2026US 2026/0306520 A1Societe des Produits Nestle S. A.
- Psma specific binding proteins for cancer diagnosis and treatment8 Oct 2026US 2026/0306582 A1Navigo Proteins GmbH
- Use of annexin v as a method to block tumor induced immunosuppression of the innate immune response8 Oct 2026US 2026/0306583 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998
- Neural regeneration peptides and methods for their use in treatment of brain damage1,465US 7,563,862 B2Neuren Pharmaceuticals Limited · 2009
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Devices and methods for treating defects in the tissue of a living being1,347US 7,166,133 B2Kensey Nash Corporation · 2007